BLA
CELG

Balter Liquid Alternatives’s Celgene Corp CELG Stock Holding History

Balter Liquid Alternatives’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,487
Closed -$159K – 271
2018
Q4 		$159K Hold
2,487
– – 0.11% 166
2018
Q3 		$223K Hold
2,487
– – 0.18% 136
2018
Q2 		$198K Buy
2,487
+322
+15% +$26.7K 0.15% 158
2018
Q1 		$193K Buy
+2,165
New +$208K 0.18% 140

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Balter Liquid Alternatives's CELG Position: Q1 2019 in Review

Balter Liquid Alternatives sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 2,487 shares — an estimated $159K sold.

Balter Liquid Alternatives first reported a position in CELG in Q1 2018 and held it in 4 quarters. The position peaked at $223K in Q3 2018. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Balter Liquid Alternatives reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Balter Liquid Alternatives sold 2,487 Celgene Corp shares in Q1 2019, an estimated $159K.
  • Balter Liquid Alternatives first reported a position in Celgene Corp in Q1 2018 and held it in 4 quarters.
  • Balter Liquid Alternatives's Celgene Corp position peaked at $223K in Q3 2018.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Balter Liquid Alternatives's 13F filing for Q1 2019, filed 13 May 2019.